Skip to product information

Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024

Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024

Regular price $50.00 USD
Regular price $50.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024

Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024

Regular price $50.00
Regular price $50.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    Date & Location


    Monday, March 18, 2024, 7:00 AM – Friday, March 22, 2024, 7:00 PM, Vail Marriott, Vail, CO

    Target Audience

    Specialties – Ophthalmology

    content : 10 videos + 31 pdfs, size: 12.2 GB

    Overview


    Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024 This Current Concepts course will highlight the recent developments regarding diagnosis as well as medical and surgical therapy of common eye diseases. The participant should get a comprehensive review of the most current concepts in the management of ophthalmology by experts across the breadth of the field.

    For example, clinical trials and other evidence in the peer-reviewed literature over the past few years have changed the approach to managing cataract including IOL technology and femtosecond laser cataract surgery, corneal disease including dry eye disease, keratoplasty, and collagen cross linking, glaucoma and minimally invasive glaucoma surgical devices, as well as diabetic retinopathy, macular degeneration, and retinal vein occlusions. Furthermore, the role of optical coherence tomography (OCT) and other imaging advances are expanding the understanding of the anatomy of the anterior and posterior segment of the eye.

    This course will address the ongoing pattern of registrants with repeat requests for demonstrations of the latest surgical techniques and medical therapies, questions regarding practice management issues and clarification of legislative updates. There is a demand for expert education of new techniques and medical therapies as well as the need for elucidation of associated clinical trials, and this course provides extensive coverage of that.

    Objectives

    1. Integrate prescribed medical and surgical treatment options into everyday practice, including uveitis, oculoplastic and ocular oncology.
    2. Assess the perioperative use of antibiotic and anti-inflammatory agents in patients undergoing eye surgery.
    3. Formulate current and advanced medical and surgical treatment strategies as well as imaging with corresponding ocular conditions, including: glaucoma, retina, anterior segment including “dry eye”, uveitis, refractive surgery and laser assisted cataract and corneal transplant surgery.
    4. Discuss new medical techniques, therapies and relevant clinical trials in dry eye, refractive surgery, cornea, glaucoma, and retina, including diabetic retinopathy, macular degeneration, and retinal vein occlusion.
    5. Assess the latest developments for the management of pediatric ophthalmology and strabismus conditions.
    6. Describe unique considerations for cataract surgery in patients with comorbid glaucoma.

     

    + Topics:

    *Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
    • Anterior Segment (Cornea) -CHAIR.pdf
    • Anterior Segment Challenges and Academic Ophthalmology – MODERATOR.pdf
    • Antibody Drug Conjugate- What are They and What Does An Ophthalmologist Need to Know About Them.pdf
    • Artificial Intelligence and Retinal Imaging.pdf
    • Blepharoplasty Basics.pdf
    • Cataract Surgery – CHAIR.pdf
    • CCV-Program-March-15-2024.pdf
    • Corneal Neurotization.pdf
    • Corticosteroids for Retinal Diseases- When Are They Considered; How Are They Delivered.pdf
    • Current Management of Keratoconus- Crosslinking, Lenses, Surgery.pdf
    • DMEK Complications.pdf
    • Endothelial Graft Inserters.pdf
    • Faricimab and High-Dose Aflibercept- Newest Anti-VEGF Agents on the Block.pdf
    • Illustrative Cases.pdf
    • Managing Refractive Error.pdf
    • March 18 Cataract Surgery.mp4
    • March 18 Managing Refractive Error – Anterior Segment.mp4
    • March 19 Anterior Segment-Cornea.mp4
    • March 19 Other Anterior Segment Topics.mp4
    • March 20 Glaucoma.mp4
    • March 20 Retina.mp4
    • March 21 Retina from the Comprehensive Ophthalmologist.mp4
    • March 21 Uveitis.mp4
    • March 22 Oculoplastics and Neuro-ophthalmology.mp4
    • March 22 Oculoplastics and Orbit.mp4
    • Non-surgical Oculoplastics Rejuvenation.pdf
    • Objective and Subjective Outcomes of Extended Depth of Focus Intraocular Lenses in Patients with Ocular Pathology.pdf
    • Oral Corticosteroids and Immunosuppression-How to Do It.pdf
    • Other Anterior Segment Topics -CHAIR.pdf
    • Patient Predictors of Advanced Technology Intraocular Lens Utilization.pdf
    • Port Delivery Systems for Retinal Diseases- Advantages and Safety.pdf
    • Rational Use of Topical Corticosteroids.pdf
    • Reducing Waste in Cataract Surgery- Quantifying the Problem and Implementing Solutions.pdf
    • Regional Variability in Endothelial Cell Loss after Intraocular Surgery.pdf
    • Severe Intraocular Inflammation with Newer Intravitreal Agents for Neovascular AMD or Geographic Atrophy.pdf
    • Starting DMEK.pdf
    • Update On Office Treatment of the Cornea Surface- Basement Membrane Opacities, Nodules, and Band Keratopathy.pdf
    • Uveitic Glaucoma.pdf
    • What’s New in Managing Double Vision in Thyroid Eye Disease..pdf
    • When to Perform DSAEK vs. DMEK.pdf
    • Wilmer Eye Institute Turns 100- Looking Back on the Last Century of Ophthalmology.pdf

    *Detail:
    Monday, March 18, 2024
    Accreditation Information and Agenda
    7:00AM – 7:10AM
    Cataract Surgery – CHAIR
    7:00AM – 10:00AM
    Yassine Daoud, MD
    Cataract Surgery – CHAIR
    7:00AM – 10:00AM
    Shameema Sikder, MD
    Interesting and Complex Cases
    7:00AM – 7:20AM
    Yassine Daoud, MD
    IOL Support in Absence of Capsular Support
    7:20AM – 7:40AM
    Yassine Daoud, MD
    Cataract Surgery in Eyes Post-Vitrectomy or Other Ocular Surgeries
    7:40AM – 8:00AM
    Shameema Sikder, MD
    Iris-Sutured IOL Repairs
    8:00AM – 8:20AM
    Yassine Daoud, MD
    Corneal Neurotization
    8:40AM – 9:00AM
    Shameema Sikder, MD
    AI Driven Performance Assessment Tools for Cataract Surgery
    9:00AM – 9:40AM
    Shameema Sikder, MD
    Case Discussions
    9:40AM – 10:00AM
    Yassine Daoud, MD
    Managing Post- Cataract Surgery Inflammation
    5:00PM – 5:20PM
    Yassine Daoud, MD
    Managing Refractive Error
    5:00PM – 6:00PM
    Christina R Prescott, MD, PhD
    Managing Refractive Error – MODERATOR
    5:00PM – 6:00PM
    Yassine Daoud, MD
    IOL Exchange vs LASIK/PRK for Refractive Surprise after Cataract Surgery
    5:20PM – 5:40PM
    Yassine Daoud, MD
    Questions and Discussion
    5:40PM – 6:00PM
    Christina R Prescott, MD, PhD
    Questions and Discussion
    5:40PM – 6:00PM
    Yassine Daoud, MD
    Anterior Segment Challenges and Academic Ophthalmology – MODERATOR
    6:00PM – 7:00PM
    Christina R Prescott, MD, PhD
    Anterior Segment Challenges and Academic Ophthalmology – MODERATOR
    6:00PM – 7:00PM
    Shameema Sikder, MD
    Current Management of Keratoconus: Crosslinking, Lenses, Surgery
    6:00PM – 6:15PM
    Michael Raizman, MD
    Wilmer Eye Institute Turns 100: Looking Back on the Last Century of Ophthalmology
    6:15PM – 6:30PM
    Peter McDonnell, MD
    Update On Office Treatment of the Cornea Surface: Basement Membrane Opacities, Nodules, and Band Keratopathy
    6:30PM – 6:45PM
    Michael Raizman, MD
    Questions and Discussion
    6:45PM – 7:00PM
    Christina R Prescott, MD, PhD
    Tuesday, March 19, 2024
    Anterior Segment (Cornea) -CHAIR
    7:00AM – 10:00AM
    Christina R Prescott, MD, PhD
    Anterior Segment (Cornea) -CHAIR
    7:00AM – 10:00AM
    Mark A Terry, MD
    Regional Variability in Endothelial Cell Loss after Intraocular Surgery
    7:00AM – 7:20AM
    Christina R Prescott, MD, PhD
    Starting DMEK
    7:20AM – 7:40AM
    Mark A Terry, MD
    Looking Forward: Challenges and Opportunities for Ophthalmology in the Next Decade
    7:40AM – 8:00AM
    Peter McDonnell, MD
    Patient Predictors of Advanced Technology Intraocular Lens Utilization
    8:00AM – 8:20AM
    Christina R Prescott, MD, PhD
    DMEK Complications
    8:40AM – 9:00AM
    Mark A Terry, MD
    Ocular Surface Complications from Systemic Medications
    9:00AM – 9:20AM
    Shameema Sikder, MD
    When to Perform DSAEK vs. DMEK
    9:20AM – 9:40AM
    Mark A Terry, MD
    Questions and Discussions
    9:40AM – 10:00AM
    Endothelial Graft Inserters
    5:00PM – 5:20PM
    Mark A Terry, MD
    Other Anterior Segment Topics -CHAIR
    5:00PM – 7:00PM
    Shameema Sikder, MD
    Other Anterior Segment Topics -CHAIR
    5:00PM – 7:00PM
    Christina R Prescott, MD, PhD
    Keratoprosthesis: Update
    5:20PM – 5:40PM
    Yassine Daoud, MD
    Reducing Waste in Cataract Surgery: Quantifying the Problem and Implementing Solutions
    5:40PM – 6:00PM
    Christina R Prescott, MD, PhD
    Role of Surgical Labs in Ophthalmic Education
    6:00PM – 6:20PM
    Shameema Sikder, MD
    Objective and Subjective Outcomes of Extended Depth of Focus Intraocular Lenses in Patients with Ocular Pathology
    6:20PM – 6:40PM
    Christina R Prescott, MD, PhD
    Questions and Discussions
    6:40PM – 7:00PM
    Shameema Sikder, MD
    Wednesday, March 20, 2024
    Glaucoma – CHAIR
    7:00AM – 10:00AM
    Thomas V Johnson III, MD, PhD
    Glaucoma – CHAIR
    7:00AM – 10:00AM
    Pradeep Ramulu, MD, PhD
    Monitoring Glaucoma from Home
    7:00AM – 7:15AM
    Thomas V Johnson III, MD, PhD
    Trabecular MIGS
    7:15AM – 7:30AM
    Jella A An, MD, MBA
    MicroPulse Transscleral Laser Therapy
    7:30AM – 7:45AM
    Jella A An, MD, MBA
    Update on Angle Closure
    7:45AM – 8:00AM
    Pradeep Ramulu, MD, PhD
    Questions and Answers
    8:00AM – 8:10AM
    Pradeep Ramulu, MD, PhD
    Questions and Answers
    8:00AM – 8:10AM
    Jella A An, MD, MBA
    Questions and Answers
    8:00AM – 8:10AM
    Thomas V Johnson III, MD, PhD
    Cataract Surgery in the Glaucoma Patient- When is Phaco Enough?
    8:25AM – 8:45AM
    Pradeep Ramulu, MD, PhD
    Update on Neuroprotection for Glaucoma: The Time Has Come
    8:45AM – 9:05AM
    Thomas V Johnson III, MD, PhD
    Retinal Ganglion Cell Regeneration: Science Fiction or Scientific Possibility?
    9:05AM – 9:20AM
    Thomas V Johnson III, MD, PhD
    Visual Fields – New tests, strategies, and tips for interpretation
    9:20AM – 9:40AM
    Pradeep Ramulu, MD, PhD
    Questions and Answers
    9:40AM – 9:45AM
    Thomas V Johnson III, MD, PhD
    Questions and Answers
    9:40AM – 9:45AM
    Pradeep Ramulu, MD, PhD
    Potential Impact of AI Chatbots: For Editors, Authors, and Readers of Peer-Reviewed Ophthalmic Literature
    9:45AM – 10:00AM
    Neil Bressler, MD
    Common Misperceptions Regarding Management of Diabetic Macular Edema, including Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
    4:20PM – 4:40PM
    Neil Bressler, MD
    Retina: Chair
    4:20PM – 7:00PM
    Jun Kong, MD, PhD
    Retina: Chair
    4:20PM – 7:00PM
    Christina Y. Weng, MD, MBA
    Home OCT-Guided Treatment versus Treat and Extend for the Management of Neovascular AMD
    4:40PM – 5:00PM
    Christina Y. Weng, MD, MBA
    Current Management of Proliferative Diabetic Retinopathy
    5:00PM – 5:20PM
    Neil Bressler, MD
    Port Delivery Systems for Retinal Diseases: Advantages and Safety
    5:20PM – 5:40PM
    Christina Y. Weng, MD, MBA
    Diabetic Macular Edema: Prophylaxis vs Treat when VA Loss
    5:40PM – 6:00PM
    Neil Bressler, MD
    Artificial Intelligence and Retinal Imaging
    6:00PM – 6:20PM
    Jun Kong, MD, PhD
    Ultrawide Field Imaging to Manage Diabetic Retinopathy Artificial Intelligence and Retinal Imaging
    6:20PM – 6:40PM
    Neil Bressler, MD
    Questions and Discussion
    6:40PM – 7:00PM
    Christina Y. Weng, MD, MBA
    Thursday, March 21, 2024
    Corticosteroids for Retinal Diseases: When Are They Considered; How Are They Delivered
    7:00AM – 7:20AM
    Christina Y. Weng, MD, MBA
    Retina for The Comprehensive Ophthalmologist: Chair
    7:00AM – 11:30AM
    Susan Bressler, MD
    Retina for The Comprehensive Ophthalmologist: Chair
    7:00AM – 11:30AM
    Christina Y. Weng, MD, MBA
    Biosimilars: They’ve Arrived in Ophthalmology
    7:20AM – 7:40AM
    Susan Bressler, MD
    Management of Symptomatic Epiretinal Membranes and DRCR Retina Network’s Protocol AM
    7:40AM – 8:00AM
    Christina Y. Weng, MD, MBA
    Faricimab and High-Dose Aflibercept: Newest Anti-VEGF Agents on the Block
    8:00AM – 8:20AM
    Susan Bressler, MD
    Faricimab and High-Dose Aflibercept: Newest Anti-VEGF Agents on the Block
    8:00AM – 8:20AM
    Christina Y. Weng, MD, MBA
    Managing the Patient with Geographic Atrophy
    8:40AM – 9:00AM
    Susan Bressler, MD
    Severe Intraocular Inflammation with Newer Intravitreal Agents for Neovascular AMD or Geographic Atrophy
    9:00AM – 9:20AM
    Jun Kong, MD, PhD
    Falls in Ophthalmology: A Potentially Overlooked Common Problem
    9:20AM – 9:40AM
    Susan Bressler, MD
    Questions and Discussion
    9:40AM – 10:00AM
    Susan Bressler, MD
    Questions and Discussion
    9:40AM – 10:00AM
    Christina Y. Weng, MD, MBA
    Imaging Workshop: A Picture is Worth A Thousand Exams
    10:15AM – 11:30AM
    Susan Bressler, MD
    Imaging Workshop: A Picture is Worth A Thousand Exams
    10:15AM – 11:30AM
    Jun Kong, MD, PhD
    Rational Use of Topical Corticosteroids
    5:00PM – 5:20PM
    Meghan Berkenstock, MD
    Uveitis -CHAIR
    5:00PM – 7:00PM
    Douglas A Jabs, MD, MBA
    Uveitis -CHAIR
    5:00PM – 7:00PM
    Meghan Berkenstock, MD
    Oral Corticosteroids and Immunosuppression:How to Do It
    5:20PM – 5:40PM
    Douglas A Jabs, MD, MBA
    Antibody Drug Conjugate: What are They and What Does An Ophthalmologist Need to Know About Them
    5:40PM – 6:00PM
    Meghan Berkenstock, MD
    Uveitic Glaucoma
    6:00PM – 6:20PM
    Douglas A Jabs, MD, MBA
    Illustrative Cases
    6:20PM – 7:00PM
    Meghan Berkenstock, MD
    Illustrative Cases
    6:20PM – 7:00PM
    Douglas A Jabs, MD, MBA
    Friday, March 22, 2024
    Lumps and Bumps: Management 101 for the Comprehensive Ophthalmologist
    7:00AM – 7:20AM
    Sara T Wester, MD
    Oculoplastics and Orbit: Chair
    7:00AM – 10:00AM
    Sophie Liao, MD
    Oculoplastics and Orbit: Chair
    7:00AM – 10:00AM
    Nicholas Mahoney, MD
    Update on the Management of Eyelid Cancers
    7:20AM – 7:40AM
    Ashley Campbell, MD
    Non-surgical Oculoplastics Rejuvenation
    7:40AM – 8:00AM
    Sophie Liao, MD
    Thyroid Eye Disease Update: Medical and Surgical Innovations
    8:00AM – 8:20AM
    Nicholas Mahoney, MD
    Treating the Tearing Patient
    8:40AM – 9:00AM
    Sara T Wester, MD
    Blepharoplasty Basics
    9:00AM – 9:20AM
    Sophie Liao, MD
    Complicated Cosmetic Cases
    9:20AM – 10:00AM
    Sara T Wester, MD
    Complicated Cosmetic Cases
    9:20AM – 10:00AM
    Sophie Liao, MD
    Complicated Cosmetic Cases
    9:20AM – 10:00AM
    Nicholas Mahoney, MD
    Complicated Cosmetic Cases
    9:20AM – 10:00AM
    Ashley Campbell, MD
    Imaging in Oculoplastics: Fractures, Tumors, Surgical Applications
    5:00PM – 5:20PM
    Nicholas Mahoney, MD
    Oculoplastics and Neuro-ophthalmology – CHAIR
    5:00PM – 7:00PM
    Andrew Carey, MD
    Oculoplastics and Neuro-ophthalmology – CHAIR
    5:00PM – 7:00PM
    Nicholas Mahoney, MD
    Acute Periorbital Infections: What Do All Ophthalmologists Need to Know
    5:20PM – 5:40PM
    Ashley Campbell, MD
    Neurosurgical Approaches to the Orbit
    5:40PM – 6:00PM
    Nicholas Mahoney, MD
    What’s New in Managing Double Vision in Thyroid Eye Disease?
    6:00PM – 6:20PM
    Andrew Carey, MD
    Advanced OCT Interpretation in Neuro-ophthalmology: Beyond Average RNFL Thickness
    6:20PM – 6:40PM
    Andrew Carey, MD
    Questions and Answers
    6:40PM – 6:50PM
    Andrew Carey, MD
    Questions and Answers
    6:40PM – 6:50PM
    Nicholas Mahoney, MD
    Closing Remarks and Adjourn
    6:50PM – 7:00PM
    Neil Bressler, MD